Infant 4.2% Sodium Bicarbonate Injection, Solution
Product Images NDC 51662-1310

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Infant 4.2% Sodium Bicarbonate (NDC 51662-1310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

How Supplied (How Supplied)

This is a table showing different pharmaceutical preparations of sodium bicarbonate with their corresponding dosages, concentrations, pH levels, and sizes. The preparations include Abboject® Syringe, Fliptop Vial, LVP Glass Container, and Abboject® Syringe for pediatric and infant use. The information provided includes information on mEq/Container, mOsmol, and mg/mL. The pH levels range from 7.0 to 8.5.*

FDA Label Image

Serialized Label (Serialized 51662 1310 1 Sodium Bicarb 4.2)

FDA Label Image

Syringe Label (Syrnge Label)

This is a description of the medication "Sodium Bicarbonate". It is administered through a single-dose infant injection, with a concentration of 5 mEq (0.5 mEq/mL). The dosage is specified in the insert and is for intravenous use only. It is sterile and nonpyrogenic, with a pH range of 7.0 to 8.5 and a concentration of 1 mOsmol/mL (calc.). This medication is manufactured by Hospira, Inc. in Lake Forest, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.